Complications; Cesarean Section Completed Phase 4 Trials for Bupivacaine (DB00297)
Also known as: Complications, Cesarean Section / Cesarean Section; Complications / Cesarean Section Complications
Indication | Status | Phase |
---|---|---|
DBCOND0036878 (Complications; Cesarean Section) | Completed | 4 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT03328533 | Norepinephrine Versus Phenylephrine Continuous Variable Infusion in Cesarean Delivery | Prevention | |
NCT05664958 | ESP Block for Post Cesarean Analgesia | Prevention | |
NCT03182088 | Norepinephrine Infusion Different Doses in Cesarean Delivery | Prevention | |
NCT03792906 | Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean Delivery | Treatment | |
NCT04897841 | Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain Control | Treatment | |
NCT04403724 | Sequential and Mixture Injection of Opioids and Hyperbaric Bupivacaine | Treatment | |
NCT03234816 | Vasopressor Prophylaxis After Spinal Anesthesia | Prevention | |
NCT03302039 | Three Protocols for Phenylephrine Administration in Cesarean Delivery | Prevention | |
NCT05502146 | Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal Hypotension | Treatment |